Asian Phytoceuticals PCLBKK:APCO-R 66 EV-to-EBITDA is 11.85 as of Jul. 05, 2026, which is 44% below its 10-year median of 21.33. GuruFocus rates BKK:APCO-R with a GF Score™ of 66/100 and a GF Value™ of ฿7.61. The stock has 4 warning signs investors should review. Among 1,629 Consumer Packaged Goods companies, Asian Phytoceuticals PCL ranks worse than 64.09% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Asian Phytoceuticals PCL's enterprise value is ฿1,151.9 Mil.
Asian Phytoceuticals PCL's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was ฿97.2 Mil. Therefore, Asian Phytoceuticals PCL's EV-to-EBITDA for today is 11.85.
The historical rank and industry rank for Asian Phytoceuticals PCL's EV-to-EBITDA or its related term are showing as below:
BKK:APCO-R'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 11.46 Med: 21.33 Max: 44.6
Current: 11.85
During the past 13 years, the highest EV-to-EBITDA of Asian Phytoceuticals PCL was 44.60. The lowest was 11.46. And the median was 21.33.
BKK:APCO-R's EV-to-EBITDA is ranked worse than 64.09% of 1629
companies
in the Consumer Packaged Goods industry
Industry Median: 9.08
vs BKK:APCO-R: 11.85
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Asian Phytoceuticals PCL (BKK:APCO-R) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Asian Phytoceuticals PCL's PE Ratio (TTM) for today is calculated as:
Asian Phytoceuticals PCL's share price for today is ฿6.2739.
Asian Phytoceuticals PCL's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿0.090.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:APCO-R vs PG, CL, KVUE: EV-to-EBITDA Comparison
For the Household & Personal Products subindustry, Asian Phytoceuticals PCL's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Asian Phytoceuticals PCL EV-to-EBITDA vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Asian Phytoceuticals PCL's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Asian Phytoceuticals PCL's EV-to-EBITDA falls into.
Asian Phytoceuticals PCL's current Enterprise Value is ฿1,151.9 Mil.
Asian Phytoceuticals PCL's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿97.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Asian Phytoceuticals PCL (BKK:APCO-R) has a EV-to-EBITDA of 11.85 as of Jul. 05, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Asian Phytoceuticals PCL. This is 44% below median its historical median of 21.33. Over the past decade, Asian Phytoceuticals PCL's EV-to-EBITDA has ranged from 11.46 to 44.60. According to the industry distribution chart, Asian Phytoceuticals PCL ranks #1044 out of 1629 companies in the Consumer Packaged Goods industry, placing it in the top 64.1%.
Is Asian Phytoceuticals PCL's EV-to-EBITDA too high?
Asian Phytoceuticals PCL's current EV-to-EBITDA of 11.85 is 44% below median its 10-year median of 21.33. Over the past 10 years, this metric has ranged from a low of 11.46 to a high of 44.60. The Consumer Packaged Goods industry median EV-to-EBITDA is 9.08. Asian Phytoceuticals PCL's value of 11.85 is 30.5% above this industry median. Based on the distribution chart, Asian Phytoceuticals PCL ranks #1044 out of 1629 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Asian Phytoceuticals PCL has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does Asian Phytoceuticals PCL's EV-to-EBITDA compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Asian Phytoceuticals PCL ranks #1044 out of 1629 companies for EV-to-EBITDA. This places Asian Phytoceuticals PCL in the lower half of its industry. The industry median EV-to-EBITDA is 9.08. Asian Phytoceuticals PCL's value of 11.85 is 30.5% above this benchmark. Historically, Asian Phytoceuticals PCL's own EV-to-EBITDA has ranged from 11.46 to 44.60 over the past decade. While the company's 10-year median is 21.33 vs. the industry median of 9.08, Asian Phytoceuticals PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Consumer Packaged Goods company?
The median EV-to-EBITDA among Consumer Packaged Goods companies is 9.08, based on 1,629 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Asian Phytoceuticals PCL's current EV-to-EBITDA of 11.85 is 30.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Asian Phytoceuticals PCL. For the Consumer Packaged Goods industry, the median EV-to-EBITDA is 9.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Asian Phytoceuticals PCL's current EV-to-EBITDA is 11.85, which is 44% below median its own 10-year median of 21.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asian Phytoceuticals PCL stock overvalued right now?
Asian Phytoceuticals PCL (BKK:APCO-R) has a current EV-to-EBITDA of 11.85. The stock's GF Value™ is ฿7.61, compared to a current price of ฿6.27 — trading 17.6% below its estimated fair value. The current EV-to-EBITDA is 11.85, which is 44% below median its 10-year median of 21.33 and 30.5% above the Consumer Packaged Goods industry median of 9.08. Asian Phytoceuticals PCL's overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Asian Phytoceuticals PCL (BKK:APCO-R), the current EV-to-EBITDA is 11.85 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Asian Phytoceuticals PCL (BKK:APCO-R) Overvalued in 2026?
Based on GuruFocus' analysis, Asian Phytoceuticals PCL stock appears to be undervalued.
The current stock price of ฿6.27 is trading 17.6% below its estimated GF Value™ of ฿7.61.
Key valuation signals for BKK:APCO-R:
EV-to-EBITDA: 11.85 (44% below median its 10-year median of 21.33)
GF Value™: ฿7.61 vs. price of ฿6.27 (17.6% below fair value)
Industry Position: 30.5% above the Consumer Packaged Goods median (#1044 of 1629)
No single metric tells the full story. See the BKK:APCO-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Asian Phytoceuticals PCL engages in the manufacturing and marketing of herbal healthcare products. The company engages in the production and distribution of dietary supplements, cosmetics, and personal care products made from natural herbs. Its beauty products include skin nourishing and skin care products, hair loss treatment and hair growth products, slimming products, dietary supplements, and other nutritional products. Geographically, the company offers its services only in Thailand.
66GF Score
Get the complete analysis for BKK:APCO-R
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:APCO-R has been successfully added to your 
